Notice of Intent to Sole Source

The Food and Drug Administration intends to sole source a purchase order to PointCross Incorporated for a Xbiom software platform license maintenance, upgrades, and support. This will provide ongoing operations, maintenance, and training for the agency's Risk Modeling and Simulation Tool, which toxicologists use to review nonclinical study data. The proposed base period is 12 months with four 12-month option periods, totaling 60 months. Interested firms must notify the contracting specialist within 14 days if they have relevant capabilities. The FDA will then determine if a competitive procurement is required.

There is no set-aside designated for this procurement. The NAICS code is 541511 and PSC code is D399. The place of performance will be within the United States. PointCross Incorporated is identified as a potential incumbent. No budget range or value is included, but the license maintenance is for a 5-year period. Responses regarding firm capabilities must be received by April 24, 2020.